Phase 1 study of LX2761 in diabetes patients
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2017
At a glance
- Drugs LX 2761 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 01 Aug 2017 According to a Lexicon Pharmaceuticals media release, data from this study is expected in second half of 2017.
- 02 May 2017 According to a Lexicon Pharmaceuticals media release, the Company anticipates the release of data this year from these studies in healthy subjects and patients with T2DM.
- 11 Jan 2017 New trial record